We are international
Donate
• about myeloma TEXT SIZE   
treatment options    back

STUDY SHOWS VELCADE® PLUS DOXIL® IMPROVES SURVIVAL IN PREVIOUSLY TREATED PATIENTS WITH MYELOMA
Data Presented at the ASCO Cancer Conference
06.04.07

Be the first to comment

 related articles